TNF- −308 promoter polymorphism in patients with rheumatoid arthritis

By Pawlik A.   Florczak M.   Ostanek L.   Brzosko M.   Brzosko I.   Szklarz B. Gawronska  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 1, 2005-02 ,pp. : 22-26

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis

By Pawlik A.   Kurzawski M.   Drozdzik M.   Dziedziejko V.   Safranow K.   Herczynska M.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 3, 2009-01 ,pp. : 159-165

Informa Healthcare

Access to resources Recommend Favorite

The genetic contribution of CTLA‐4 dimorphisms in promoter and exon 1 regions in Japanese patients with rheumatoid arthritis

By Takeuchi F.   Kawasugi K.   Mori M.   Nakaue N.   Kobayashi N.   Kuwata S.   Murayama T.   Matsuta K.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 2, 2006-04 ,pp. : 154-155

Informa Healthcare

Access to resources Recommend Favorite

IL-10 Gene Promoter Polymorphisms in Rheumatoid Arthritis

By Hajeer Ali   Lazarus Mark   Turner David   Mageed Rizgar   Vencovsky Jiri   Sinnott Paul   Hutchinson Ian   Ollier William  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 2, 1998-08 ,pp. : 142-145

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor- (TNF-) levels and influence of −308 TNF- promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis

By Cuchacovich M   Ferreira L   Aliste M   Soto L   Cuenca J   Cruzat A   Gatica H   Schiattino I   Pérez C   Aguirre A   Salazar-Onfray F   Aguillón JC  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 228-232

Informa Healthcare

Access to resources Recommend Favorite